HARROW, INC. — Director's Dealing 2014

Oct 3, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2014-09-30

Reporting Person: Kammer Robert J (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-30	Common Stock	M	25000	$4.50	Acquired	969979	Direct
2014-09-30	Common Stock	F	15162	$7.42	Disposed	954817	Direct
2014-09-30	Common Stock	M	46875	$4.50	Acquired	1001692	Direct
2014-09-30	Common Stock	F	28428	$7.42	Disposed	973264	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-09-30	Stock Option (Right to Buy)	$4.50	M	25000	Disposed	2014-09-30	Common Stock (25000)	Direct
2014-09-30	Stock Option (Right to Buy)	$4.50	M	46875	Disposed	2014-09-30	Common Stock (46875)	Direct

Footnotes

F1: All stock options are fully exercisable.

F2: The stock option was granted on April 1, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan and the shares subject to the option became exercisable over a 1 year period, with 6,250 such shares becoming exercisable on each of June 30, 2012, September 30, 2012, December 31, 2012 and March 31, 2013.

F3: The stock option was granted on April 1, 2012 under the Issuer's 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 2 year period, with 15,000 such shares becoming exercisable immediately upon issuance and an additional 1,875 such shares becoming exercisable monthly for the next twenty four months thereafter.

F4: On September 30, 2013 the expiration date of the option was amended to be September 30, 2014 rather than March 31, 2017.